Last Updated: May 5, 2026

DOBUTAMINE HYDROCHLORIDE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Dobutamine Hydrochloride, and what generic alternatives are available?

Dobutamine Hydrochloride is a drug marketed by Baxter Hlthcare, Dr Reddys, Hikma, Hospira, Luitpold, Slate Run Pharma, Teligent, Teva Parenteral, Watson Labs, and Watson Labs Inc. and is included in fifteen NDAs.

The generic ingredient in DOBUTAMINE HYDROCHLORIDE is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Dobutamine Hydrochloride

A generic version of DOBUTAMINE HYDROCHLORIDE was approved as dobutamine hydrochloride by HOSPIRA on November 29^th, 1993.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for DOBUTAMINE HYDROCHLORIDE?
What are the global sales for DOBUTAMINE HYDROCHLORIDE?
What is Average Wholesale Price for DOBUTAMINE HYDROCHLORIDE?

Summary for DOBUTAMINE HYDROCHLORIDE

US Patents:	0
Applicants:	10
NDAs:	15

US Patents and Regulatory Information for DOBUTAMINE HYDROCHLORIDE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	DOBUTAMINE HYDROCHLORIDE	dobutamine hydrochloride	INJECTABLE;INJECTION	074381-001	Sep 26, 1996		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Baxter Hlthcare	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	dobutamine hydrochloride	INJECTABLE;INJECTION	020255-004	Oct 19, 1993	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Luitpold	DOBUTAMINE HYDROCHLORIDE	dobutamine hydrochloride	INJECTABLE;INJECTION	074545-001	Jun 25, 1998		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.